Recombinant Zoster Vaccine [RZV] is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study.

Aakash DesaiJana G HashashGursimran S KochharMary S HayneyFreddy CalderaFrancis A Farraye

Published in: Journal of Crohn's & colitis (2024)

RZV is associated with a lower long-term risk of HZ in patients ≥50 years old with IBD. Given the widespread availability and safety of RZV, more effective vaccination strategies are needed to improve RZV use in this high-risk population.

Keyphrases

patients with inflammatory bowel disease
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
cell free